Adolescent WIN Exposure Changed Later Dopamine-Neuron Drug Responses in Rats
A rat experiment found lasting differences in dopamine-neuron responses after adolescent exposure to WIN 55,212-2. Cross-tolerance to several later drug challenges appeared after adolescent exposure but not after the corresponding adult exposure.
This was a neuronal recording study
Rats received the synthetic cannabinoid agonist or vehicle for three days during adolescence or adulthood. After a two-week interval, investigators recorded activity from identified dopamine neurons and their target cells under anesthesia. This design measured neuronal responses, rather than voluntary drug taking or later addiction in people.
Age modified the cross-drug result
Dopamine neurons were significantly less responsive to WIN's stimulating action after either adolescent or adult pretreatment. However, the adolescent-pretreated group also developed lasting cross-tolerance to morphine, cocaine and amphetamine challenges. That additional cross-drug pattern was not reported for the adult-pretreated group.
A cellular response does not settle future behavior
The authors interpreted the results as enduring neuronal adaptation following cannabinoid exposure at a young age. Reduced neuronal responsiveness is not equivalent to reduced drug risk, and it is not proof that an animal would seek larger doses. The abstract does not establish those behavioral outcomes or quantify a corresponding risk in adolescents who use cannabis.
The study contributes a controlled age comparison with a defined delay before testing. Its relevance depends on retaining those details and the identity of the synthetic agonist. It should not be described as direct evidence that ordinary marijuana exposure causes a particular future pattern of human drug use.
Related: interpreting cannabis tolerance claims.
Research cited
Pistis M; Perra S; Pillolla G; Melis M; Muntoni AL; Gessa GL. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biological psychiatry (2004). doi:10.1016/j.biopsych.2004.05.006. Findings discussed from the study abstract.
